Lanzul

Lansoprazole, the active ingredient in Lanzul, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and Helicobacter pylori eradication therapy.

GNH USA supplies Lanzul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lanzul, a proton pump inhibitor, acts on the gastric acid secretion pathway to treat several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the oesophageal lining. - Peptic ulcer disease: facilitates ulcer healing by lowering gastric acidity. - Helicobacter pylori eradication: used in combination regimens to eradicate the bacterium. - Erosive esophagitis: promotes mucosal repair by suppressing acid injury.

Adverse reactions may occur with Lanzul and are categorized by frequency.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Diarrhea: loose, watery stools occurring intermittently. - Nausea: sensation of unease and urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: excess gas causing bloating. - Constipation: infrequent or difficult bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Stevens‑Johnson syndrome: painful skin lesions and mucosal involvement. - Elevated liver enzymes: signs of hepatic stress detectable in labs. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before prescribing Lanzul, consider the following safety measures. - Assess renal function: adjust use in patients with severe impairment. - Monitor for infection: be alert to signs of C. difficile colitis. - Review concomitant medications: avoid or adjust drugs that interact significantly. - Use caution in pregnancy: limited data, weigh benefits against potential risks. - Store at room temperature: keep in the original pack, protect from moisture.

Lanzul may interact with other medicines; interactions vary in clinical significance.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption. - Atazanavir: decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Phenytoin: may lower phenytoin levels, adjust dose if needed. - Methotrexate: risk of increased toxicity, check serum levels.